Found: 5
Select item for more details and to access through your institution.
Patient Characteristics Associated with Time to Next Treatment in Patients with Ovarian Cancer Treated with Niraparib: The PRED1CT Real-World Study.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 599, doi. 10.1007/s40487-024-00294-3
- By:
- Publication type:
- Article
Real-World Outcomes Following First-Line Treatment in Patients with Advanced Ovarian Cancer with Multiple Risk Factors for Disease Progression who Received Maintenance Therapy or Active Surveillance.
- Published in:
- Oncology & Therapy, 2023, v. 11, n. 2, p. 245, doi. 10.1007/s40487-023-00227-6
- By:
- Publication type:
- Article
E-Selectin Genotypes and Risk of Type 2 Diabetes in Women<sup>**</sup>.
- Published in:
- Obesity (19307381), 2005, v. 13, n. 3, p. 513, doi. 10.1038/oby.2005.54
- By:
- Publication type:
- Article
Cytochrome P450--inhibiting/inducing Medication Use Among Patients With Advanced Ovarian Cancer (aOC) Who Received or Were Eligible for Poly(ADP-ribose) Polymerase Inhibitors (PARPis) as First-line Maintenance Therapy.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2023, v. 14, n. 11, p. 354
- By:
- Publication type:
- Article
Using metabolic syndrome traits for efficient detection of impaired glucose tolerance.
- Published in:
- 2004
- By:
- Publication type:
- journal article